Serum KL-6 Levels in Interstitial Lung Diseases (ILDs) Associated to Connective Tissue Diseases (CTDs)

被引：0
|
作者：
Moreer, Lise [1 ]
Nunes, Hilario [1 ]
Bondeelle, Louise [1 ]
Uzunhan, Yurdagul [1 ]
Ghillani-Dalbin, Pascale [2 ]
Valeyre, Dominique [1 ]
Musset, Lucile [2 ]
Miyara, Makoto [2 ]
机构：
[1] Avicenne Hosp, AP HP, Dept Pulm Dis, Bobigny, France
[2] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2907
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Serum Kl-6 Level As A Prognostic Indicator In Connective Tissue Disease-Associated Interstitial Lung Disease
    Baba, H.
    Jinta, T.
    Okada, M.
    Takahashi, O.
    Okafuji, K.
    Kitamura, A.
    Tomishima, Y.
    Nishimura, N.
    Chohnabayashi, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [22] SERUM KL-6 LEVEL REFLECTS SEVERITY OF INTERSTITIAL LUNG DISEASEASSOCIATED WITH CONNECTIVE TISSUE DISEASE
    Lee, J. S.
    Lee, E. Y.
    Park, J. K.
    Ha, Y. -J.
    Kang, E. H.
    Lee, Y. J.
    Song, Y. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 809 - 809
  • [23] Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
    Spagnolo, Paolo
    Distler, Oliver
    Ryerson, Christopher J.
    Tzouvelekis, Argyris
    Lee, Joyce S.
    Bonella, Francesco
    Bouros, Demosthenes
    Hoffmann-Vold, Anna-Maria
    Crestani, Bruno
    Matteson, Eric L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02) : 143 - 150
  • [24] THE SIGNIFICANCE OF KL-6, SP-D AND SP-A IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASES (CTD-ILDS)
    Yang, Junling
    Yan, Bingdi
    Zhang, Qinghua
    Zhao, Fenglian
    Ren, Jin
    RESPIROLOGY, 2015, 20 : 85 - 85
  • [25] Treatment of interstitial lung diseases associated with connective tissue diseases
    Kobayashi, Akiko
    Okamoto, Hiroshi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (02) : 219 - 227
  • [26] Value of KL-6 in diagnosis of connective tissue disease with interstitial lung disease
    Xue, W.
    Lijun, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 860 - 860
  • [27] KL-6 as a potential therapeutic biomarker in fibrosing interstitial lung diseases
    Somogyi, Vivien
    Mayer, Katharina
    Kriegsmann, Katharina
    Kriegsmann, Mark
    Findeisen, Peter
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [28] Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study
    Oguz, Ekin Oktay
    Kucuksahin, Orhan
    Turgay, Murat
    Yildizgoren, Mustafa Turgut
    Ates, Askin
    Demir, Nalan
    Kumbasar, Ozlem Ozdemir
    Kinikli, Gulay
    Duzgun, Nursen
    CLINICAL RHEUMATOLOGY, 2016, 35 (03) : 663 - 666
  • [29] Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study
    Ekin Oktay Oguz
    Orhan Kucuksahin
    Murat Turgay
    Mustafa Turgut Yildizgoren
    Askin Ates
    Nalan Demir
    Ozlem Ozdemir Kumbasar
    Gulay Kinikli
    Nursen Duzgun
    Clinical Rheumatology, 2016, 35 : 663 - 666
  • [30] Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases
    Zamora, Ana C.
    Wesselius, Lewis J.
    Gotway, Michael B.
    Tazelaar, Henry D.
    Diaz-Arumir, Alejandro
    Nagaraja, Vivek
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 287 - 304
12345